JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on July 20, 2007
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/29/20847    most recent
M703847200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shiryaev, S. A.
Right arrow Articles by Strongin, A. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiryaev, S. A.
Right arrow Articles by Strongin, A. Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print May 30, 2007
J. Biol. Chem, 10.1074/jbc.M703847200
Submitted on May 10, 2007
Revised on May 25, 2007
Accepted on May 30, 2007

Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens

Sergey A. Shiryaev, Albert G. Remacle, Boris I. Ratnikov, Nicholas A. Nelson, Alexei Y. Savinov, Ge Wei, Massimo Bottini, Michele F. Rega, Amelie Parent, Roxane Desjardins, Robert Day, Mojgan Sabet, Maurizio Pellecchia, Robert C. Liddington, Jeffrey W. Smith, Tomas Mustelin, Donald G. Guiney, Michal Lebl, and Alex Y. Strongin

Cancer Research Center, The Burnham Institute, La Jolla, CA 92037

Corresponding Author: strongin{at}burnham.org

Pathogens or their toxins, including influenza virus, pseudomonas and anthrax toxins, require processing by host proprotein convertases (PCs) to enter host cells and to cause disease. Conversely, inhibiting PCs is likely to protect host cells from multiple furin-dependent, but otherwise unrelated, pathogens. To determine if this concept is correct, we designed specific nanomolar inhibitors of PCs modeled from the extended cleavage motif TPQRERRRKKRGL of the avian influenza H5N1 hemagglutinin (HA). We then confirmed the efficacy of the inhibitory peptides in vitro against the fluorescent peptide, anthrax protective antigen (PA83) and influenza HA substrates and also in mice in vivo against two unrelated toxins, anthrax and Pseudomonas exotoxin. Peptides with Phe/Tyr at P1’ were more selective for furin. Peptides with P1’ Thr were potent against multiple PCs. Our strategy of basing the peptide sequence on a furin cleavage motif known for an avian flu virus shows the power of starting inhibitor design with a known substrate. Our results confirm that inhibiting furin-like PCs protects the host from the distinct furin-dependent infections and lay a foundation for novel, host cell-focused therapies against acute diseases.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. G. Remacle, S. A. Shiryaev, E.-S. Oh, P. Cieplak, A. Srinivasan, G. Wei, R. C. Liddington, B. I. Ratnikov, A. Parent, R. Desjardins, et al.
Substrate Cleavage Analysis of Furin and Related Proprotein Convertases: A COMPARATIVE STUDY
J. Biol. Chem., July 25, 2008; 283(30): 20897 - 20906.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.